Clinical effects of naftopidil on nocturia associated with benign prostatic hyperplasia
We studied the efficacy of naftopidil (50 mg/day) on nocturia associated with benign prostatic hyperplasia in 35 patients (62-80 years old). The patients had BPH > 20 ml, nocturia, more than 3 times, international prostate symptom score (IPSS) > 7, quality of life score (QOL) < 1, and maxim...
| Publié dans: | Hinyokika kiyo. Acta urologica Japonica. - 1962. - 49(2003), 8 vom: 07. Aug., Seite 445-9 |
|---|---|
| Auteur principal: | |
| Autres auteurs: | , , , , , |
| Format: | Article |
| Langue: | Japanese |
| Publié: |
2003
|
| Accès à la collection: | Hinyokika kiyo. Acta urologica Japonica |
| Sujets: | Clinical Trial English Abstract Journal Article Multicenter Study Adrenergic alpha-Antagonists Naphthalenes Piperazines naftopidil R9PHW59SFN |